5-Ethoxy-1-methyl-1H-pyrazole-4-carboxylic acid, 97.0%, 1g

Rociletinib, 99%, 100mg

DANSYLAMIDE, 98%, 1g

(S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxypropanoate, 95.0%, 1g

2-(pyrrolidin-1-yl)propan-1-amine; oxalic acid, 95.0%, 500mg

3-Bromopyridine-n-oxide, 95.0%, 5g

Methyl 6-chloro-2-pyrazinecarboxylate, 95.0%, 100g

({3-[2-(acetylamino)ethyl]-1H-indol-5-yl}oxy)acetic acid, 1g

2,3-Pyridinediamine, 6-methyl-, 95%, 10g

Benzoic acid benzyl ester, min. 99%, for synthesis, 250 ml, glass packaging

2-Bromo-1,1,1-triethoxypropane, 98%, 100mg

2-METHYL-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 100mg

Round bottom flask with standard ground joint 6000 ml NS 45/40